To kill or to cure: Options in host defense against viral infection

Current Opinion in Immunology

Volumn 8, Issue 4, 1996, Pages 478-483

  Guidotti, Luca G ^a   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B VIRUS; HOST RESISTANCE; HUMAN; LIVER; LIVER CELL; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE; VIRAL GENETICS; VIRUS INFECTION;

EID: 0030219913     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80034-3     Document Type: Article

References (58)

1. Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med. 160:1984;814-826.
2. Kägi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen J, Podack ER, Zinkernagel R, Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994;31-37.
3. Walsh CM, Matloubian M, Liu C, Ueda R, Kurahara CG, Christensen JL, Huang MTF, Young JD-E, Ahmed R, Clark WR. Immune function in mice lacking the perforin gene. Proc Natl Acad Sci USA. 91:1994;10854-10858.
4. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. of special interest Annu Rev Immunol. 13:1995;29-60 A comprehensive review of HBV immunobiology and pathogenesis in humans and transgenic mice. The immunological basis for viral clearance and viral persistence is critically discussed.
5. Razvi ES, Jiang Z, Woda BA, Welsh RM. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr and Bcl-2 mice. Am J Pathol. 147:1995;79-91.
6. Yoo JY, Howard R, Waggoner JG, Hoofnagle JH. Peroxidase - anti-peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis. J Med Virol. 23:1987;273-281.
7. Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest. 97:1996;1655-1665.
8. Guidotti LG, Matzke B, Schaller H, Chisari FV. High level hepatitis B virus replication in transgenic mice. J Virol. 69:1995;6158-6169.
9. Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, Schreiber RD, Schlicht HJ, Huang S, Chisari FV. Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol. 152:1994;3245-3253.
10. Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, Kanagawa O, Chisari FV. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science. 248:1990;361-364.
11. Wirth S, Guidotti LG, Ando K, Schlicht HJ, Chisari FV. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in HBV envelope transgenic mice. J Immunol. 154:1995;2504-2515.
12. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. of outstanding interest Immunity. 4:1996;25-36 The first direct evidence that physiologic concentrations of antiviral cytokines induced by antigen-specific CTLs can noncytopathically abolish viral gene expression and replication.
13. Gilles PN, Fey G, Chisari FV. Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol. 66:1992;3955-3960.
14. Guidotti LG, Guilhot S, Chisari FV. Interleukin-2 and interferon alpha/beta downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor dependent and independent pathways. J Virol. 68:1994;1265-1270.
15. Guilhot S, Guidotti LG, Chisari FV. Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a post-transcriptional mechanism. J Virol. 67:1993;7444-7449.
16. Tsui LV, Guidotti LG, Ishikawa T, Chisari FV. Post-transcriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. of special interest Proc Natl Acad Sci USA. 92:1995;12398-12402 HBV-specific CTLs noncytopathically downregulate most HBV RNAs in the hepatocycte nucleus by a cytokine-dependent post-transcriptional mechanism that involves recognition of virus-specific sequences contained in the longest viral transcripts. These results suggest that noncytopathic cytokine-dependent clearance of a virus may occur only if the virus genome (or its products) carries appropriate responsive elements.
17. Davis GL, Hoofnagle JH, Waggoner JG. Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon. J Med Virol. 14:1984;141-147.
18. Sheen I-S, Liaw Y-F, Lin D-Y, Chu C-M. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis. 170:1994;1358-1361.
19. Lohler J, Gossman J, Kratzberg T, Lehmann-Grube F. Murine hepatitis caused by lymphocytic choriomeningitis virus. I. The hepatic lesions. Lab Invest. 70:1994;263-277.
20. Oldstone MBA, Blount P, Southern PJ, Lampert PW. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 321:1986;239-243.
21. Ahmed R, Jamieson BD, Porter DD. Immune therapy of a persistent and dissiminated viral infection. J Virol. 61:1987;3920-3929.
22. Fung-Leung W-P, Kunding TM, Zinkernagel RM, Mak TW. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J Exp Med. 174:1991;1425-1429.
23. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J Virol. 61:1987;1867-1874.
24. Pircher H, Bürki K, Lang R, Hengartner H, Zinkernagel RM. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 342:1989;559-561.
25. King CC, Jamieson BD, Reddy K, Bali N, Concepcion RJ, Ahmed R. Viral infection of the thymus. J Virol. 66:1992;3155-3160.
26. Guidotti LG, Borrow P, Hobbs MV, Matzke B, Gresser I, Oldstone MBA, Chisari FV. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. of special interest Proc Natl Acad Sci USA. 93:1996;4589-4594 HBV replication in the hepatocytes of HBV-transgenic mice is noncytopathically abolished by cytokines (particularly TNFα and IFNα/β) produced by LCMV-infected macrophages in the absence of an LCMV-specific T-cell response. Evidence is provided of an important role for cytokines produced by macrophages in viral clearance, and that LCMV itself is resistant to the antiviral cytokines it induces even though they readily control HBV replication.
27. Uchida T, Kronborg I, Peters RL. Acute viral hepatitis: morphological and functional correlations in human livers. Hum Pathol. 15:1984;267-277.
28. Kajino K, Jilbert AR, Saputelli J, Aldrich C, Cullen J, Mason WS. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol. 68:1994;5792-5803.
29. Jilbert AR, Wu T-T, England JM, De La Hall PM, Carp NZ, O'Connell AP, Mason WS. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol. 66:1992;1377-1388.
30. Martz E, Howell DM. CTL: virus control cells first and cytolytic cells second? Immunol Today. 10:1989;79-86.
31. Müller U, Steinhoff U, Reis LFL, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
32. Moskophidis D, Battegay M, Bruendler M-A, Laine E, Gresser I, Zinkernagel R. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and gamma interferon. J Virol. 68:1994;1951-1955.
33. Gegin C, Lehmann-Grube F. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J Immunol. 149:1992;3331-3338.
34. Lehmann-Grube F, Assmann U, Loliger C, Moskophidis D, Lohler J. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. J Immunol. 134:1985;608-615.
35. Sambhi SK, Kohonen-Corish MRJ, Ramshaw IA. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo. Proc Natl Acad Sci USA. 88:1991;4025-4029.
36. Kohonen-Corish MRJ, King NJC, Woodhams CE, Ramshaw IA. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-γ Eur J Immunol. 20:1990;157-161.
37. Van Den Broek MF, Müller U, Huang S, Aguet M, Zinkermagel RM. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. of special interest J Virol. 69:1995;4792-4796 LCMV and vaccinia virus replicate much faster in mice that lack both IFN α/β and γ receptors.
38. γ.
39. Rossol-Voth R, Rossol S, Schütt KH, Corridori S, De Cian W, Falke D. In vivo protective effect of tumor necrosis factor α against experimental infection with herpes simplex virus type I. J Gen Virol. 72:1991;143-147.
40. γ is required to clear herpes simplex virus from the eye.
41. + effector T cell can eliminate influenza virus in respiratory epithelial cell that MHC lack class II expression. The involvement of cytokines and/or antibody is discussed.
42. Hwang SY, Hertzog PJ, Holland KA, Sumarsono SH, Tymms MJ, Hamilton JA, Whitty G, Bertoncello I, Kola I. A null mutation in the gene encoding a type I interferon receptor component eliminates anti-proliferative responses to interferons α and β and alters macrophage responses. of special interest Proc Natl Acad Sci USA. 92:1995;11284-11288 Semliki Forest virus replicates uncontrollably in several organs of mice that lack a component of the IFN α/β receptor.
43. Fiette L, Aubert C, Müller U, Huang S, Aguet M, Brahic M, Bureau J-F. Theiler's virus infection of 129Sv mice that lack the interferon α/β or interferon γ receptors. of special interest J Exp Med. 181:1995;2069-2076 IFN α/β and γ play a non-redundant role in the control of Theiler's virus infection.
44. Horisberger M, Staeheli P, Haller O. Interferon induces unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci USA. 80:1983;1910-1914.
45. Staeheli P, Pavlovic J. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J Virol. 65:1991;4498-4501.
46. Kumar R, Choubey D, Lengyel P, Sen GC. Studies on the role of 2′-5′-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication. J Virol. 62:1988;3175-3181.
47. Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H, Kirchner H. Antiviral effect of recombinant tumor necrosis factor in vitro. Nature. 323:1986;816-819.
48. Wong GHW, Goeddel DV. Tumor necrosis factor α and β inhibit virus replication and synergize with interferons. Nature. 323:1986;819-822.
49. + cells involves a non-cytotoxic mechanism. J Virol. 65:1991;5921-5927.
50. Balter M. Elusive HIV-suppressor factors found. Science. 270:1995;1560-1561.
51. Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci USA. 88:1991;2888-2892.
52. Kalvakolanu DVR, Bandyopadhyay SK, Harter ML, Sen GC. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins; block in transcriptional complex formation. Proc Natl Acad Sci USA. 88:1991;7459-7463.
53. Adler H, Jungi TW, Pfister H, Strasser M, Sileghem M, Peterhans E. Cytokine regulation by virus infection: bovine viral diarrhea virus, a flavivirus, downregulates production of tumor necrosis factor alpha in macrophages in vitro. J Virol. 70:1996;2650-2653.
54. Symons JA, Alcami A, Smith GL. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell. 81:1995;551-560.
55. Upton C, Mossman K, McFadden G. Encoding a homolog of the interferon-γ receptor by myxoma virus. Science. 258:1992;1369-1372.
56. Alcami A, Smith GL. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol. 69:1995;4633-4639.
57. Schreiber M, McFadden G. The myxoma virus TNF-receptor homologue (T2) inhibits tumor necrosis factor-α in a species-specific fashion. Virology. 204:1994;692-705.
58. McFadden G, Graham K, Ellison K, Barry M, Macen J, Schreiber M, Mossman K, Nash P, Lalani A, Everett H. Interruption of cytokine networks by poxviruses: lessons from myxoma virus. of special interest J Leukoc Biol. 57:1995;731-738 A very detailed review describing the virokines and viroreceptors produced during myxoma virus infection and their interactions with the cytokine network.